Cangrelor 50 mg/1
Cangrelor · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Gland Pharma Limited
No Recall History
Plain English
Cangrelor is a injection, powder, lyophilized, for solution containing cangrelor at 50 mg/1, taken intravenous. Manufactured by Gland Pharma Limited.
Key Facts
- Brand Name
- Cangrelor
- Generic Name
- Cangrelor
- NDC Code (Product)
68083-412- Manufacturer
- Gland Pharma Limited
- Strength
- 50 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA213551
- Drug Class
- P2Y12 Platelet Inhibitor [EPC]
- Marketing Start
- 08/11/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Cangrelor used for?
Cangrelor contains Cangrelor. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Cangrelor a controlled substance?
Cangrelor is not classified as a controlled substance by the DEA.
What is the generic name for Cangrelor?
The generic name for Cangrelor is Cangrelor. There are 1 other brand versions of Cangrelor.
What is the NDC code for Cangrelor 50 mg/1?
The NDC (National Drug Code) for Cangrelor 50 mg/1 is 68083-412, listed by Gland Pharma Limited.